TopNews New ZealandHeart failure risk for diabetes patientsWebMD.Boots.com10th December 2012 – People with diabetes are almost 65% more likely to have heart failure than the rest of the population in England and Wales, the latest figures show. They are…
Ten days before Christmas, Petaluma resident Janice MacKinnon received a call that would change her
Veloxis' STRATO study shows reduction in tremor in kidney transplant patientspharmabiz.comTacrolimus is a leading immunosuppression drug used for the prevention of transplant allograft rejection after organ transplantation. LCP Tacro is an investig…
What's happening today in the north valleyEnterprise-RecordA benefit for Open Doors Literacy Project and Shalom Free Clinic, Gayle Kimball, Susan Tchudi and Stephen Tchudi share photos from their recent trip to northern India. Topics include religi…
Washington, Dec 10 (IANS) A new drug halves the risk of serious and often deadly side-effect of lifesaving bone marrow transplant treatments, according to a new finding.
Headaches – why you should take them more seriouslyIndia.Com HealthAcetaminophen should be used with caution in patients with liver disorders or high alcohol intake, since it increases the risk of liver damage. Overuse of such OTC pain relievers displa…
BBC NewsDiabetes fuels heart failure riskBBC NewsPeople with diabetes are up to 65% more likely to have heart failure, an analysis has found. The National Diabetes Audit looked at data on almost two million people and also found increased risk of other…
Bringing world class education to the heart of IndiaTimes of IndiaWith India being a nation that matters to the world, Delhi, the capital city, has stood to gain a lot, especially in the education sector. The changing face of Delhi has been very pleasa…
Technologies to diagnose bacterial disease, scan for melanoma and tackle headaches are among the hottest tickets in healthcare innovation for 2013
HealioIbrutinib Effective and Safe Treatment Option in CLLMedscapeAlthough chemoimmunotherapy approaches such as fludarabine, cyclophosphamide, and rituximab have markedly improved outcomes, primarily of younger, fit patients, fludarabine-based therapy…